Your search returned 5 results.

Sort
Results
1.
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. MedStar authors:
  • Ratner, Robert E
PMID:
  • 25603459
Year: 2015
Citation:
  • Journal of Clinical Endocrinology & Metabolism. 100(5):1855-62, 2015 May.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Adam KP, Banerji M, Bray GA, Buchanan TA, Clement SC, Cobb JE, DeFronzo RA, Ferrannini E, Gall W, George T, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D
2.
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW. MedStar authors:
  • Ratner, Robert E
PMID:
  • 24705615
Year: 2014
Citation:
  • Diabetes Care. 37(6):1706-11, 2014 Jun.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
Form of publication:
  • Journal Article
All authors:
  • Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D
3.
PPAR activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia. MedStar authors:
  • Campia, Umberto
  • Matuskey, Linda A
  • Panza, Julio A
PMID:
  • 24769306
Year: 2014
Citation:
  • Atherosclerosis. 234(2):436-40, 2014 Jun.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Campia U, Cardillo C, Matuskey LA, Panza JA, Tesauro M
4.
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors:
  • Ratner, Robert E
PMID:
  • 23175674
Year: 2013
Citation:
  • Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
Form of publication:
  • Journal Article
All authors:
  • Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D
5.
Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). MedStar authors:
  • Ratner, Robert E
PMID:
  • 21359834
Year: 2012
Citation:
  • The International Journal of Cardiovascular Imaging. 28(3):455-65, 2012 Mar.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • APPROACH study group, Brugaletta S, Garcia-Garcia HM, Garg S, Huang C, Kolatkar NS, Kravitz BG, Miller DM, Morocutti G, Nesto RW, Ratner RE, Serruys PW
Pages

Powered by Koha